COVID-19 English to Russian Medical Medical: Pharmaceuticals

Clinical laboratories with residual SARS-CoV-2 positive specimens displaying unusual result features on molecular testing.
*S-gene target failures* are not currently considered unusual result features.
To obtain approval:
Call the COVID-19 Clinical Lab Consortium Coordinator at the Oregon State Public Health Laboratory at 503-693-4100 (main laboratory) or 503-508-4228 (cell).
For specimens not meeting these criteria, clinicians may pursue COVID-19 sequencing at their discretion through academic and commercial laboratories.